Marco Lobba
Marco Lobba obtained a PhD from the University of California Berkeley and was a former student in the labs of Nobel Laureate Jennifer Doudna and Matthew Francis, Emeritus Chair of the Berkeley Department of Chemistry. In addition, he holds a bachelor’s degree in from Pomona College. With his educational foundation rooted at the intersection of chemistry and molecular biology and gene editing, Dr. Lobba cofounded CatenaBio to address the pressing challenge of delivering targeted protein therapeutics. His expertise in protein conjugation has helped advance innovative treatments, such as CRISPR-based editors and cell-based therapies. Dr. Lobba’s academic background and experience at UC Berkeley have shaped his vision for revolutionizing precision medicine and developing therapies that were previously unimaginable.